The FDA approved AMX0035 (Relyvrio) for amyotrophic lateral sclerosis (ALS) Thursday; new research suggests looking at microbes and fungi within cancer tumors; US suicides increased in 2021 following a 2-year decrease in deaths by suicide.
The FDA approved experimental drug AMX0035 (Relyvrio) for amyotrophic lateral sclerosis (ALS) Thursday, The Washington Post reported. AMX0035 was developed to slow the effects of ALS by protecting nerve cells in the brain and spinal cord damaged by the neurological condition. The approval was granted despite it being a much-debated drug with questions about its efficacy. However, some individuals living with ALS said a treatment with any amount of efficacy is important, as this was the first approval for an ALS treatment in 5 years.
New research suggested looking at microbes and fungi within cancer tumors rather than treating tumors as if they are sterile, The New York Times reported. A team of researchers detected bacteria living in pancreatic tumors in 2017, prompting further research on how a species of bacteria could block a chemotherapy drug from working and later finding bacteria in tumors of 7 types of cancer. Using these findings, another team of researchers found that a small percentage of DNA fragments in 32 types of cancer belonged to bacteria rather than humans. The 2 research teams collaborated and found that, in 35 different types of cancer, all of them contained fungi and each had a distinctive combination of fungal species.
Following a 2-year decrease in suicides in 2019 and 2020, US suicides have risen again, with experts saying rates are returning to prepandemic levels, The Wall Street Journal reported. This finding is based on data from the National Center for Health Statistics. The report stated 47,646 Americans died by suicide in 2021, reflecting a nearly 4% increase compared with the still high count of 45,979 deaths by suicide in 2020. It also said men aged between 15 and 24 years experienced the sharpest increase with an 8% rise in 2021. Notably, despite the onset of the COVID-19 pandemic, suicide rates did not markedly increase in 2020.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Awareness of “Food Is Medicine” Programs Is Low, But Interest Is High
August 28th 2025Targeted “Food is Medicine” interventions can help individuals with diet-sensitive chronic conditions improve their health, but nationally representative survey and qualitative interviews showed low awareness despite high interest among respondents.
Read More
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Housing Assistance May Help Renters With Cancer Better Withstand Medical Financial Strain
August 28th 2025Housing assistance significantly reduces medical financial hardship for renters with a history of cancer, enhancing their financial security and access to care amid rising health costs.
Read More
Patients With HFpEF May Benefit From Accelerated Cardiac Pacing
August 28th 2025In an observational extension of the myPACE clinical trial, researchers found that a personalized accelerated pacing in patients with heart failure with preserved ejection fraction (HFpEF) and a preexisting physiological pacer saw a slower trend in adverse cardiac events and overall improved health status.
Read More